Missing/wrong data?
Log in to edit
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
scientific article published on 13 July 2015
Author/s
author: Rodryg Ramlau, Adolfo Favaretto, Sergey Orlov, Armando Santoro, Brian Schwartz, Lecia V Sequist, Silvia Novello
Work details
Publication date
July 13, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.